Jessica Flannery – Why and How Clinical Science Should Go Beyond Consult Roles and be Embedded for Behavioral Health Tech Product Development

*** Proof of Product ***

---

Exploring the Essential Features of “Jessica Flannery – Why and How Clinical Science Should Go Beyond Consult Roles and be Embedded for Behavioral Health Tech Product Development”

Speaker: Jessica Flannery, PhD

Duration: 1 Hour

Format: Audio and Video

Copyright: Nov 15, 2023  

Media Type: Digital Seminar

Description

Digital therapeutics (DTx) have tremendous potential to increase accessible, scalable, and equitable mental and behavioral health care. In the early development of this field, clinician’s primary interactions with product teams have been as a subject matter expert consultation. However, as the field of DTx expands, there is burgeoning recognition of the potential benefit of greater clinical science involvement in product life cycles to improve patient engagement and outcomes. This changing landscape in product development, however, doesn’t come without challenges. By delving into clinical sciences’ evolving impact in the development of DTx, this talk aims to uncover untapped potential for clinical science to integrate within the product life cycle, while highlighting current challenges and practical tips to navigate this cross-functional role.

Speaker

Jessica Flannery, PhD, is translational scientist, practicing clinician and developmental researcher who is passionate about innovating mental health care solutions for youth in service of developing accessible, yet equitable interventions. As the head of clinical science at Limbix, she spearheaded clinical science initiatives across product, clinical, science, research, and business stakeholders to develop evidence-based and engaging digital products to improve youth mental health. With over 10 years of experience in clinical psychology and developmental social neuroscience, she leverages her expertise in mental health, youth social development, scientific rigor, cross-functional collaboration, and technology to drive innovation and improve patient outcomes.

Speaker Disclosures:
Financial: Jessica Flannery has an employment relationship with Dogwood Psychology. She had a prior employment relationship with Limbix Health. She has a family member that receives compensation from Verily. Jessica Flannery receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Jessica Flannery is an ad hoc reviewer for several publications, for a complete list contact PESI, Inc.

Objectives

1. Evaluate criteria for the translation of evidence-based treatment to digital therapeutics.
2. Appraise opportunities to contribute to the development of DTx for mental and behavioral health.
3. Develop practical skills to enhance productive collaboration between clinical science and product.

Outline

Untapped Potential for Clinical Scientists with DTx

• The Benefits
• The Challenges & Limitations
• The Application & Practical Tips

Burgeoning Areas of Influence for Clinical Scientists with DTx Product Development

• The Benefits
• The Challenges & Limitations
• The Application & Practical Tips

The Future Potential for Clinical Scientists within DTx Product Development

• The Benefits
• The Challenges & Limitations
• The Application & Practical Tips

Target Audience

• Counselors
• Marriage and Family Therapists
• Social Workers
• Physicians 
• Psychologists

Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/